TickerFacts.

Immucell Corp (ICCC): Gross Profit

Annual figures by period end, from SEC filings.

$11.45M
Year ended 2025-12-31
$12.37M
Trailing 12 months to 2026-06-30
+14.4%
3-year compound annual growth
+10.8%
5-year compound annual growth
+6.2%
10-year compound annual growth
2009-12-31: $2.40M2010-12-31: $2.30M2011-12-31: $2.81M2012-12-31: $3.05M2013-12-31: $3.06M2014-12-31: $4.45M2015-12-31: $6.25M2016-12-31: $5.42M2017-12-31: $5.22M2018-12-31: $5.19M2019-12-31: $6.74M2020-12-31: $6.86M2021-12-31: $8.66M2022-12-31: $7.65M2023-12-31: $3.87M2024-12-31: $7.94M2025-12-31: $11.45M$11.45M
2009-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$11.45M+44.1%2026-03-30, From 2025-01-01
2024-12-31$7.94M+105.2%2026-03-30, From 2024-01-01
2023-12-31$3.87M-49.4%2025-03-28, From 2023-01-01
2022-12-31$7.65M-11.6%2024-04-01, From 2022-01-01
2021-12-31$8.66M+26.1%2023-03-29, From 2021-01-01
2020-12-31$6.86M+1.8%2022-03-30, From 2020-01-01
2019-12-31$6.74M+29.8%2021-03-30, From 2019-01-01
2018-12-31$5.19M-0.5%2020-03-27, From 2018-01-01
2017-12-31$5.22M-3.7%2019-03-22, From 2017-01-01
2016-12-31$5.42M-13.3%2018-03-29, From 2016-01-01
2015-12-31$6.25M+40.5%2017-03-30, From 2015-01-01
2014-12-31$4.45M+45.4%2016-03-25, From 2014-01-01
2013-12-31$3.06M+0.2%2016-03-25, From 2013-01-01
2012-12-31$3.05M+8.5%2015-03-26, From 2012-01-01
2011-12-31$2.81M+22.2%2014-03-26, From 2011-01-01
2010-12-31$2.30M-4.0%2013-03-28, From 2010-01-01
2009-12-31$2.40Mn/a2012-03-27, From 2009-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Immucell Corp (ICCC)2025-12-31$11.45M+44.1%
Alpha Teknova, Inc. (TKNO)2025-12-31$13.44M+85.9%
Aspira Women's Health Inc. (AWHL)2025-12-31$5.92M+8.0%
Anbio Biotechnology (NNNN)2025-12-31$7.54M+28.2%
Biomerica Inc (BMRA)2026-05-31$362.0K-27.3%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$2.30M+210.5%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$1.34Mn/a
Myriad Genetics Inc (MYGN)2025-12-31$576.60M-1.5%
Neogen Corp (NEOG)2026-05-31$408.50M-3.1%

Compare ICCC, TKNO, AWHL, NNNN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗